chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with Inability to breath while exercising, worsening to inability to breath walking .25 on flat ground.  Heart Arrhythmia Immune system is unable to fight other viruses effectively. IE: takes longer to recover from the common cold. Breathing issues and heart arrhythmia get worse when immune system is active.
fever  chills  nausea no vomiting  fainting x 1 body aches arm swelling
Varicella Information has been received from a health professional concerning a 12 month old white female who on 06-JAN-2006 was vaccinated with a 0.5ml subcutaneous dose in the left arm of varicella virus vaccine live (Oka/Merck) (Lot# 649992/0791R). Concomitant therapy included montelukast sodium (MSD) and budesonide (Pulmicort). Concomitant vaccine administered on same day included a first subcutaneous dose in the right arm of measles mumps rubella vaccine (MSD) (Lot # 648679/0609P) and a fourth intramuscular dose in the left thigh of Hib conj vaccine (tet toxoid) (ACTHIB) (Lot #UE767AN). Concomitant vaccine also included a fourth intramuscular dose in the right thigh of pneumococcal 4 5B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (Lot# A259694). "Late January 2006, around the 2st", the patient broke out in a chickenpox-like rash. She had been breaking out in the lesions over the course of 3 days. It was unknown how many lesions there were. At the time of the report the patient's chickenpox-like rash persisted. Unspecified medical attention was sought. No product quality complaint was involved. No there information was provided. Follow-up information from a health professional indicated that the patient had a rash since 22-JAN2--6, with red bumps all over and was fussy but negative for fever. A physical exam showed that the patient was not ill appearing, but had an erythematous papular lesions in the various stages of eruption on her face, extremities and trunk. The impression was varicella . The patient was treated with diphenhydramine hydrochloride (Benadryl), 1/2 tsp. oral administration. The patient recovered on 29-JAN-2006. Additional information is not expected.
the day after vaccination had burning down center of my back and in both knees.   on day 5 skin started to itch and woke up with hives all over body.
pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain in her arm). At the time of the report, MYALGIA (pain in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug was not reported. Treatment for the event was not reported.
Pfizer 4/1/21, 4/22/21, 12/6/21. Positive on 1/2/23
On May 13, I started having itchiness and skin flaking on my hands and ankles. On June 8, I saw my dermatologist; she prescribed a gel to apply to the itchy areas on hands and ankles. It improved and was gone completely in a few days, by about June 12. On June 15, I noticed a new itchy, lesion on my arm, and in the crook of my elbow. Over the next few days, more itchy lesions appeared (9 in total) on my legs and 1 on my abdomen; they became filled with a fluid. I showed it to a pharmacist and also contacted my Primary Care physician at Primary Care, to ask if it could be Monkey Pox. Based on the symptoms I described she said no. I applied antibiotic cream to the lesions and they went away gradually over the next 3 weeks. Itching is now completely gone and scars seem to be gradually disappearing.
Pt received HPV4 vaccine injection on 8/7/09 at about 4:30pm. She developed a 4-5 inch diameter area if hives around the injection site at about 9pm. She also has had a sore arm and shoulder. However, her mother said she had been jet sking all day the day before and that may account for the shoulder/arm discomfort. Mother gave her Benadryl at home and the hives went away. No other sx were noted.
This case was reported by a pharmacist and described the occurrence of red rash injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). In October 2008, the subject received a dose of FLUARIX (.5 ml, unknown). In October 2008, at an unspecified time after vaccination with FLUARIX, the subject experienced red rash injection site and pharmaceutical product complaint. The pharmacist received a call from a nurse at a nursing home facility that reported that 80 out of 100 subjects developed a "grapefruit size bright red" rash at the injection site. At the time of reporting the outcome of the events was unspecified. For the other 70 linked subjects please see cases: A0756483A - A0756516A, A0756518A - A0756562A. The CRC provided lot number AFLUA3208A to QA regarding this product complaint, while the report received in CMG Safety stated AFLUA3508A. With a possibility of a coding mistake to batch AFLUA 320AA and on the basis that there were 80 cases out of 100, it was decided to ask for a Quality investigation (including cold chain) of all three batches (correct numbers: AFLUA350BA, AFLUA320BA and AFLUA320AA). On 16 January 2009, QA results were received for batches reviewed of (AFLUA320AA and AFLUA 320BA): AFLUCA320, AFLUA320A, and AFLUA320B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batches AFLUA320AA and AFLUA320BA. On 26 March 2009, QA results were received for batches reviewed (AFLUA350BA): AFLUCA350 and AFLUA350B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batch AFLUA350BA.
pt recv vax 30OCT96 & 23DEC96 pt devel flu sx of fever, nausea, anorexia, weakness & labored breathing;pt seen by MD;no tx were prescribed;pt has not yet recovered as of 30DEC96;
Patient reports several areas of bruising and "smell and dots" which resolved after 1 week.
hot area around injection site; itchy area around injection site; Red area around injection site; swollen area around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot area around injection site), VACCINATION SITE PRURITUS (itchy area around injection site), VACCINATION SITE ERYTHEMA (Red area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m2oa) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included ALPHA LIPOIC ACID, GABAPENTIN, GLIMEPIRIDE, METFORMIN, METOPROLOL, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), COENZYME Q10 [UBIDECARENONE], VITAMIN D [VITAMIN D NOS] and VITAMIN B12 NOS for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot area around injection site), VACCINATION SITE PRURITUS (itchy area around injection site), VACCINATION SITE ERYTHEMA (Red area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site). At the time of the report, VACCINATION SITE WARMTH (hot area around injection site) and VACCINATION SITE SWELLING (swollen area around injection site) had not resolved and VACCINATION SITE PRURITUS (itchy area around injection site) and VACCINATION SITE ERYTHEMA (Red area around injection site) had resolved.            On 26-FEB-2021, patient had circular area about 3-4 inches in diameter around the injection site that was red, hot, swollen and itchy. The area got worse until 28-FEB-2021 when it started getting a little better. At the time of report, the area was still swollen and hot.  Patient applied Cold washcloth on the area as treatment.   This case was linked to MOD-2021-230147 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up report included no new information
CAN NOT MOVE; FLU LIKE SYMPTOMS/FEELING VERY WEAK/WARM TO TOUCH/FEVER; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included heart condition. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100 deg. On 16-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 103 deg. On an unspecified date, the subject experienced can not move, and flu like symptoms/feeling very weak/warm to touch/fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 99, 99.6. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient had not recovered from flu like symptoms/feeling very weak/warm to touch/fever, and the outcome of can not move was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious
Myocarditis   Patient developed chest pain 1 day after vaccination. Presented to hospital on 2/6/22 for chest pain and had elevated troponin. Transferred to our facility  from other facility. Initial troponin at our facility was 2.296. Troponin peaked on 2/8/22 at 5.873 and then trended down after getting pulse dose steroids (Methylprednisolone 1000 mg daily x 3 doses). Troponin at discharge was 1.008. Patient discharge with steroid taper and follow-up with cardiology.
Pt recv vax on 12/8/97; on 6/2/98 pt exp joint pain
Patient had the usual malaise, joint pain, & muscle pain, but also had some blistering around the waistline
Redness, swelling 3 1/4" X 4" anterio-lateral left thigh.
got a bad case of the flu; Initial information received on 14-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves adult male patient who experienced got a bad case of the flu while receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine (strength, formulation, route, dose, frequency: unknown) produced by unknown manufacturer lot number not reported via unknown administration site for Prophylactic vaccination.  On an unknown date the patient developed a non-serious got a bad case of the flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (got a bad case of the flu).  At time of reporting, the outcome was Unknown for the event got a bad case of the flu.
Developed cellulitis around injection site spreading down arm. Was seen in ER sent home on oral antibiotics after a course of IV antibiotics overnight.
reported as a medication error due to patient receiving double doses of vaccine products (with no reported adverse event); Initial information received on 01-Nov-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 1-year-old male patient and the reporter reported as a medication error due to patient receiving double doses of vaccine products (with no reported adverse event) after receiving vaccine diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis B vaccine for Immunisation.  On 31-Oct-2023, the patient received a 0.5 ml dose of suspect diphtheria-15/tetanus/5 AC pertussis vaccine, Suspension for injection (strength: unknown) (lot: C6013AA, expiry date: 07-Jun-2024) in the left thigh for Immunization and reported as a medication error due to patient receiving double doses of vaccine products (with no reported adverse event) (extra dose administered) (latency: same day).  Reportedly, Caller states the patient was behind on a vaccinations and was on a catch up regimen. Patient was due for about 6 to 7 vaccine products, but the parents wanted to only get a few vaccines at a time. The prescribing doctor wrote the order for "Penta, DTaP, Polio, and hib" at the bottom of the order which may have confused the MA that administered the vaccine products    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA344255:
I was out of two visiting my grandkids over 10/30/2022 and 10/31/2022 weekend. I began to feel unwell on 11/01/2021,, on that Tuesday, 11/03/2021 was tested positive for COVID., requested and received the IV-Infusion on 11/04/2021, Micrcongrial IV. I am unsure if I am recovered since there is a thing as long COVID, and I feel it is too early to tell.
1 week after receiving vaccine. 85 year old patient experienced fainting and very low blood pressure.
Pt received both AVA #6 and Typhoid #2 on 11 Apr 07, she went home that prn and had a pos home pregnancy test. Went to clinic the next day and preg test was positive. G1 PO; Her LMP was 5 Mar. She was on birth control but ran out last month and was waiting for her period to resume. She stated they used condoms except for a couple of times. Amenorrhea start: 04/12/2007
4 days after the second shot of the Pfizer vaccine that was given in my right arm,  I got a lump in my right armpit, that is still there and causes me pain sometimes.  I also had 3 episodes of high fever after the second shot:  first 12 hours after the shot, then  again 4 days after the shot and a third time 1 week after the shot. I called a doctor and he recommended me to have a Covid test, that I did and was negative for Covid-19.   I still have the lump in my armpit after  6 months of the vaccine and will therefore have a consultation with my doctor in the next days.
After vaccination, a temperature excursion was discovered in the fridge where the vaccine was kept. Per manufacturer, the vaccine was no longer viable. Spoke with patient who reports no side effects. Advised to repeat the dose based on CDC recommendations.
Patient reported a tingling feeling in his right arm (vaccine administered in left arm).   Tingling described as going from his elbow to his pinkie and ring fingers.
Moderna COVID-19 Vaccine EUA Burning with urination, urgency to urinate. Symptoms lasted 7 days.  Additional symptoms of sore arm, headache, elevated temperature, and fatigue began at the same time, but lasted only 1 day.
Acute viral syndrome, nausea, vomiting, generalized rash, headache, body aches, painful swollen joints, sore throat, uvulitis, blisters on hands, profound neutropenia.
At approximately 24 hours post vaccine, sites of injection were red,warm, and pruritic. Scratching caused excoriation. Area of redness size of palm of adult hand. No fever. Normal walking , very happy and pleasant.
Have killed and injured millions of people, including me; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (Have killed and injured millions of people, including me) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Have killed and injured millions of people, including me). At the time of the report, IMMUNISATION REACTION (Have killed and injured millions of people, including me) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was reported.  The patient was experienced adverse event due to Moderna and Pfizer COVID-19 vaccine.  No treatment medication was reported.
The evening after the shot, I began experienced headache, sore muscles neck and back, fatique.  The next day I had chills clogged sinuses and runny nose, cough, and fatigue , sore muscles and headache continued.  These symptoms improved somewhat by Saturday (4 days after) but I am continuing to have a cough and runny nose as well as eye pain when moving eyes.
Body aches, fever, chills, bad taste in mouth that burns and has a metal taste in mouth
injections were more than six months apart; This case was reported by a consumer via SHINGRIX interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided are as follows: The case was reported by patient himself/ herself. The age at vaccination was not reported. The reporter reported that his/her Shingrix injections were more than six months apart, which led to drug dose administration interval too long. he reporter asked if that was okay. The follow-up would not possible as no contact details were available.
Syncopal episode x 2, red hand/forearm same side as injection.  Seen in ER, diagnosed varovagal reaction, no evidence allergic reaction.
THE PATIENT RECEIVED BOTH VACCINES IN THE SAME ARM 2 DAYS AGO. HE PRESENTED TO THE PHARMACY WITH A DIFFUSE RASH ALL OVER HIS TRUNK, LEGS AND ARMS. HIS FACE, NECK AND THROAT WERE UNAFFECTED. THE PATIENT ALSO HAS REDNESS AND A "SORE LUMP" AT THE INJECTION SITE.  HE HAS HAD A FEVER FOR A FEW HOURS EVERY NIGHT SINCE THE INJECTION. IT GOES AWAY BY MORNING.
I wanted to report this possible error which in case of a recall could have been disastrous or an adverse reaction. The lot# on the FLUZONE had an I and 1 next to each other. "I1" which on the bottle can easily by mistaken by nurses and those entering the vaccines into our system.  I was hoping manufacturing companies would know to not confuse people with I versus 1 and just for the future to never confuse person with 0 versus O as well.
Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient developed pain. Shoulder movement has been limited. He is seeing physical therapist and doctor.
Patient received 0.5ml of 6m-11yr Moderna Monovalent COVID vaccine instead of 0.25ml.
Information has been received from a registered nurse concerning an approximately 18 year old male with no known drug allergies or medical history who in December 1989, was vaccinated with first dose of MMR. On 19-AUG-2006, the patient received his second dose of MMR. There was no concomitant medication. Subsequently the patient had a negative titer for rubella. No symptoms were reported. Additional information has been requested.
Pt experienced a 4 x 4 cm area that was indurated and erythematous. Non tender, itchy hives on right upper thigh. No purulent drainage. Symptoms started a few hours post vax.
Fever to 103.2 x2 days and febrile seizure within 48h of administration. Seizure lasted <1 min.
Post vax, the pt developed a local reaction consisting of urticaria. Urticaria was also located on the torso and extremities.
Pt first noticed rash on (R) shoulder that same night. Then over course of next few days, rash had progressed to chest, abd & thighs.
Periorbital, perioral, anterior neck rash with urticaria and peeling skin to all mentioned sites.  Patient given dexamethasone 8 mg IM in office on 4/16/21 and prescribed hydroxyzine pamoate 25 mg and prednisone 20 mg.  Rash flared again on 4/18 and patient had chills and "felt hot".  Patient taking prednisone 20 mg 1 PO on 4/17/21, prednisone 20 mg 1 PO BID on 4/18/21, and prednisone 20 mg 1 PO on 4/19/21.
Information has been received from a pharmacist concerning an approximately 70 year old female patient who "a few years ago" was vaccinated with a dose of PNEUMOVAX 23 (Dose, route and Lot# not reported). Pharmacist stated that on an unspecified date the patient experienced an allergic reaction to PNEUMOVAX 23 and developed rash. Pharmacist also stated that the patient on unspecified date took BENADRYL for the rash and it went away. The patient sought unspecified medical attention. No further information is available.
Patient came in for a second dose of Moderna. When we went into system to document we discovered she received a dose in March 2021 and was told by her physician to restart the series. Her card only had a dose received December 29, 2021. According to her record she has received three .50 ml's of Moderna. Please advice.
From Tuesday injection day counting - On Thursday, Third day after, upper left arm developed a 6" x 5" oval reddish skin color in injection area that is warm and itches off and on.  Periodic sharp jabs from area.  On Friday, Fourth day after, have put Cortisone cream on  area to help with itching to no avail.  Will be taking Benadryl antihistamine Friday night.
The patient had soreness in his arm that soon after developed into pain in the upper arm especially when raising his arm.  A small knot still present at the site. No systemic symptoms. Plans to see PMD if no improvement.
Extreme nausea. Did not dare move in bed or would have vomited and no one available to clean up if I did. lasted about 4 hrs then started sipping ginger beer then dry plain toast, then tea then at supper tolerated chicken noodle soup. did rept tp PCP.
Redness, swelling, skin hot to the touch, head and face burning, sore muscles, red rash like on arms, neck, face, and chest. Fullness feeling in tongue. Itching chest, shoulders, and arms. Joint pain and tingling in hands, fingers, legs and feet. Started a little over 2 days after vaccination and still continuing.